FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Laboratories Divalproex Sodium Extended-Release Tablets Recall

Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Jun 24, 2015
Recall ID
D-1135-2015
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Divalproex Sodium Extended-Release Tablets starting May 22, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1135-2015 on Jun 24, 2015. Reason: Failed Dissolution Specifications; exceeded specification at the 9 hour time point. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications; exceeded specification at the 9 hour time point

Product description

Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-533-05) bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories Limited, Bachupally 500 090 India

Lot numbers, UPCs & expiration codes

100 count bottle - Lot #C307859, exp 09/2015; 500 count bottle - Lot #C307859 and Lot# C307812, exp 09/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1135-2015
Classification
Class II
Status
Terminated
Recall initiated
May 22, 2015
FDA report date
Jun 24, 2015
Quantity
100 count 7479; 500 count - 2544
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-1135-2015, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
71374
Address
107 College Rd E
Code information
100 count bottle - Lot #C307859, exp 09/2015; 500 count bottle - Lot #C307859 and Lot# C307812, exp 09/2015
Postal code
08540-6623
Report date
Jun 24, 2015
Product type
Drugs
Recall number
D-1135-2015
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
100 count 7479; 500 count - 2544
Termination date
Apr 24, 2017
Reason for recall
Failed Dissolution Specifications; exceeded specification at the 9 hour time point
Voluntary / mandated
Voluntary: Firm initiated
Product description
Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-533-05) bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories Limited, Bachupally 500 090 India
Distribution pattern
Nationwide
Recall initiation date
May 22, 2015
Initial firm notification
Letter
Center classification date
Jun 12, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1135-2015, published Jun 24, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls